Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Nutrients ; 12(10)2020 Oct 15.
Article in English | MEDLINE | ID: mdl-33076301

ABSTRACT

Enteropathogenic and enterohemorrhagic Escherichia coli are important enteric pathogens that induce hemorrhagic colitis or even fatal hemolytic uremic syndrome. Emerging evidence shows that some bio-actives derived from fruits and vegetables may serve as alternatives to antibiotics for overcoming multidrug resistant E. coli infections. In this study, the Citrobacter rodentium (Cr) infection model was utilized to mimic E. coli-induced acute intestinal inflammation, and the effects of a cruciferous vegetable-derived cancer protective compound, indole-3-carbinol (I3C), on the immune responses of Cr-susceptible C3H/HeN mice were investigated. Dietary I3C significantly inhibited the loss of body weight and the increase in spleen size in Cr infected mice. In addition, I3C treatment reduced the inflammatory response to Cr infection by maintaining anti-inflammatory cytokine IL-22 mRNA levels while reducing expression of other pro-inflammatory cytokines including IL17A, IL6, IL1ß, TNF-α, and IFN-γ. Moreover, the serum cytokine levels of IL17, TNF-α, IL12p70, and G-CSF also were down-regulated by I3C in Cr-infected mice. Additionally, dietary I3C specifically enhanced the Cr-specific IgG response to Cr infection. In general, dietary I3C reduced the Cr-induced pro-inflammatory response in susceptible C3H/HeN mice and alleviated the physiological changes and tissue damage induced by Cr infection but not Cr colonization.


Subject(s)
Anti-Bacterial Agents , Anti-Inflammatory Agents , Brassicaceae/chemistry , Citrobacter rodentium , Dietary Supplements , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/immunology , Escherichia coli Infections/drug therapy , Escherichia coli Infections/immunology , Immunoglobulin G/immunology , Indoles/administration & dosage , Phytotherapy , Splenomegaly/drug therapy , Animals , Cytokines/metabolism , Disease Models, Animal , Enterobacteriaceae Infections/complications , Enterobacteriaceae Infections/pathology , Escherichia coli Infections/complications , Escherichia coli Infections/pathology , Indoles/isolation & purification , Indoles/pharmacology , Inflammation Mediators/metabolism , Interleukins/metabolism , Male , Mice, Inbred C3H , Mice, Inbred C57BL , Splenomegaly/etiology , Splenomegaly/pathology , Interleukin-22
2.
Cancer Prev Res (Phila) ; 9(7): 607-15, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27138790

ABSTRACT

There is a strong belief that garlic has medicinal properties and may even reduce the risk of developing certain cancers including those of the gastrointestinal tract. The chemopreventive effects of garlic may be attributed to the anti-inflammatory properties of the sulfur-containing constituents of garlic, which includes diallyl disulfide (DADS). Here, we demonstrate that DADS prevented colorectal tumorigenesis in a mouse model of colitis-induced colorectal cancer. Supplementation with 85 ppm of DADS (60 mg daily human equivalent dose) in the diet of FVB/N mice treated with chemical carcinogen azoxymethane (AOM) and colonic irritant dextran sodium sulfate (DSS) resulted in the reduction in tumor incidence, tumor number, and tumor burden by 21.54%, 47.3%, and 66.4%, respectively. Further analysis revealed that mice fed the DADS-supplemented diet resolved the initial DSS-induced inflammation faster than those on the control diet, preventing prolonged inflammation and cellular transformation. Subsequent mechanistic studies in vitro suggest that DADS chemopreventive effects are mediated through NF-κB signaling. When SW480 colorectal cancer cells were treated with DADS, NF-κB nuclear localization and activity were diminished. Interestingly, NF-κB suppression was found to be dependent on DADS inhibition of GSK-3ß, a positive regulator of NF-κB. Inhibition of GSK-3ß and loss of nuclear NF-κB activity were also observed in vivo in AOM/DSS-treated mice fed a diet supplemented with 85 ppm DADS. Our results indicate that DADS can prevent tumorigenesis by suppressing inflammation, a process largely involving GSK-3ß inhibition and consequential reduction in NF-κB nuclear localization. Cancer Prev Res; 9(7); 607-15. ©2016 AACR.


Subject(s)
Allyl Compounds/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Carcinogenesis/drug effects , Colorectal Neoplasms/pathology , Disulfides/pharmacology , Glycogen Synthase Kinase 3 beta/metabolism , Plant Extracts/pharmacology , Animals , Cell Line, Tumor , Cell Proliferation/drug effects , Colitis/chemically induced , Colitis/complications , Colorectal Neoplasms/etiology , Garlic/chemistry , Glycogen Synthase Kinase 3 beta/drug effects , Humans , Inflammation/chemically induced , Inflammation/pathology , Mice , NF-kappa B/drug effects , NF-kappa B/metabolism
3.
Mol Carcinog ; 54(9): 669-78, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25845339

ABSTRACT

An important characteristic of cancer is that the disease can overcome the surveillance of the immune system. A possible explanation for this resistance arises from the ability of tumor cells to block the tumoricidal activity of host immune cells such as natural killer (NK) cells by inducing the localized accumulation of regulatory T (Treg) cells. Evidence exists that components in commonly consumed foods including vitamins A, D, and E, water-soluble constituents of mushrooms, polyphenolics in fruits and vegetables, and n-3 fatty acids in fish oil can modulate NK cell activities, Treg cell properties, and the interactions between those two cell types. Thus, it is extremely important for cancer prevention to understand the involvement of dietary components with the early stage dynamics of interactions among these immune cells. This review addresses the potential significance of diet in supporting the function of NK cells, Treg cells, and the balance between those two cell types, which ultimately results in decreased cancer risk.


Subject(s)
Diet , Killer Cells, Natural/immunology , Neoplasms/immunology , Neoplasms/prevention & control , T-Lymphocytes, Regulatory/immunology , Animals , Cytokines/immunology , Fatty Acids, Omega-3/immunology , Humans , Neoplasms/diet therapy , Polyphenols/immunology , Vitamin A/immunology , Vitamin D/immunology
4.
Cancer Res ; 73(17): 5473-84, 2013 Sep 01.
Article in English | MEDLINE | ID: mdl-23824743

ABSTRACT

Analysis of the Polyp Prevention Trial showed an association between an isorhamnetin-rich diet and a reduced risk of advanced adenoma recurrence; however, the mechanism behind the chemoprotective effects of isorhamnetin remains unclear. Here, we show that isorhamnetin prevents colorectal tumorigenesis of FVB/N mice treated with the chemical carcinogen azoxymethane and subsequently exposed to colonic irritant dextran sodium sulfate (DSS). Dietary isorhamnetin decreased mortality, tumor number, and tumor burden by 62%, 35%, and 59%, respectively. MRI, histopathology, and immunohistochemical analysis revealed that dietary isorhamnetin resolved the DSS-induced inflammatory response faster than the control diet. Isorhamnetin inhibited AOM/DSS-induced oncogenic c-Src activation and ß-catenin nuclear translocation, while promoting the expression of C-terminal Src kinase (CSK), a negative regulator of Src family of tyrosine kinases. Similarly, in HT-29 colon cancer cells, isorhamnetin inhibited oncogenic Src activity and ß-catenin nuclear translocation by inducing expression of csk, as verified by RNA interference knockdown of csk. Our observations suggest the chemoprotective effects of isorhamnetin in colon cancer are linked to its anti-inflammatory activities and its inhibition of oncogenic Src activity and consequential loss of nuclear ß-catenin, activities that are dependent on CSK expression.


Subject(s)
Colorectal Neoplasms/prevention & control , Phytotherapy , Plant Extracts/pharmacology , Quercetin/analogs & derivatives , beta Catenin/metabolism , src-Family Kinases/metabolism , Animals , Apoptosis/drug effects , Azoxymethane/toxicity , Blotting, Western , CSK Tyrosine-Protein Kinase , Cell Nucleus/metabolism , Cell Proliferation/drug effects , Colorectal Neoplasms/chemically induced , Colorectal Neoplasms/metabolism , Dextran Sulfate , Humans , Immunoenzyme Techniques , Male , Mice , Protein Transport , Quercetin/pharmacology , RNA, Messenger/genetics , RNA, Small Interfering/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured , beta Catenin/genetics , src-Family Kinases/antagonists & inhibitors , src-Family Kinases/genetics
5.
Mol Carcinog ; 52(9): 676-85, 2013 Sep.
Article in English | MEDLINE | ID: mdl-22495798

ABSTRACT

Sirtinol is a purported specific inhibitor of the nicotinamide adenine dinucleotide (NAD)-dependent type III histone deacetylase (also known as sirtuin). Sirtinol has been used extensively to identify chemopreventive/chemotherapeutic agents that modulate the sirtuins. However, the molecular effect of sirtinol other than serving as sirtuin inhibitor in cells is less clear. The present study addressed this deficiency in the literature. Based on structural similarity with plant-derived cancer preventive/therapeutic compounds such as 3', 3'-diindolylmethane, resveratrol, and genistein, we hypothesized that sirtinol may act on pathways similar to that affected by these compounds in the human prostate cancer cell LNCaP. We found that treatment of LNCaP cells with sirtinol led to concentration-dependent effects on multiple pathways. Sirtinol inhibited LNCaP cell cycle and growth that was correlated with up-regulation of cyclin-dependent kinase inhibitor 1A mRNA and protein levels. This effect of sirtinol may due in part to modulation of androgen, estrogen, and insulin-like growth factor-1 mediated pathways as sirtinol treatment led to inhibition of mRNA and protein expression of marker genes involved in these pathways. We also found sirtinol activates aryl hydrocarbon-dependent pathways in LNCaP cells. The effects of sirtinol were observed at 25 µM, a concentration lower than Ki (38 µM) for sirtuin activity. Based on these results we reasoned that sirtinol exerts pleiotropic effects in cells and that biological effects of sirtinol may not be due solely to inhibition of sirtuin.


Subject(s)
Androgens/metabolism , Benzamides/pharmacology , Naphthols/pharmacology , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Signal Transduction/drug effects , Sirtuins/antagonists & inhibitors , Androgens/genetics , Anticarcinogenic Agents/pharmacology , Cell Cycle/drug effects , Cell Cycle/genetics , Cell Line, Tumor , Cell Proliferation/drug effects , Cyclin-Dependent Kinase Inhibitor p21/genetics , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Cytochrome P-450 CYP1A1/genetics , Cytochrome P-450 CYP1A1/metabolism , Estrogens/genetics , Estrogens/metabolism , Humans , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/metabolism , Male , NAD(P)H Dehydrogenase (Quinone)/genetics , NAD(P)H Dehydrogenase (Quinone)/metabolism , Phytotherapy , Prostatic Neoplasms/genetics , Receptors, Cytoplasmic and Nuclear/genetics , Signal Transduction/genetics , Sirtuins/genetics , Sirtuins/metabolism , Up-Regulation/drug effects
6.
J Nutr Biochem ; 23(7): 691-8, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22704055

ABSTRACT

Cancer stem cells often have phenotypic and functional characteristics similar to normal stem cells including the properties of self-renewal and differentiation. Recent findings suggest that uncontrolled self-renewal may explain cancer relapses and may represent a critical target for cancer prevention. It is conceivable that the loss of regulatory molecules resulting from inappropriate consumption of specific foods and their constituents may foster the aberrant self-renewal of cancer stem cells. In fact, increasing evidence points to the network delivering signals for self-renewal from extracellular compartments to the nucleus including changes in stem cell environments, inducible expression of microRNAs, hyperplastic nuclear chromatin structures, and the on/off of differentiation process as possible sites of action for bioactive food components. Diverse dietary constituents such as vitamins A and D, genistein, (-)-epigallocatechin-3-gallate (EGCG), sulforaphane, curcumin, piperine, theanine and choline have been shown to modify self-renewal properties of cancer stem cells. The ability of these bioactive food components to influence the balance between proliferative and quiescent cells by regulating critical feedback molecules in the network including dickkopf 1 (DKK-1), secreted frizzled-related protein 2 (sFRP2), B cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1) and cyclin-dependent kinase 6 (CDK6) may account for their biological response. Overall, the response to food components does not appear to be tissue or organ specific, suggesting there may be common cellular mechanisms. Unquestionably, additional studies are needed to clarify the physiological role of these dietary components in preventing the resistance of tumor cells to traditional drugs and cancer recurrence.


Subject(s)
Neoplastic Stem Cells/drug effects , Neoplastic Stem Cells/pathology , Alkaloids/pharmacology , Benzodioxoles/pharmacology , Catechin/analogs & derivatives , Catechin/pharmacology , Cell Differentiation , Cell Proliferation , Choline/pharmacology , Curcumin/chemistry , Cyclin-Dependent Kinase 6/genetics , Cyclin-Dependent Kinase 6/metabolism , Diet , Epigenesis, Genetic , Gene Expression Regulation , Genistein/pharmacology , Glutamates/pharmacology , Humans , Intercellular Signaling Peptides and Proteins/genetics , Intercellular Signaling Peptides and Proteins/metabolism , Isothiocyanates , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mesenchymal Stem Cells/drug effects , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Piperidines/pharmacology , Plant Extracts/administration & dosage , Plant Extracts/pharmacology , Polycomb Repressive Complex 1 , Polyunsaturated Alkamides/pharmacology , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism , STAT1 Transcription Factor/genetics , STAT1 Transcription Factor/metabolism , Sulfoxides , Thiocyanates/pharmacology , Vitamin A/pharmacology , Vitamin D/pharmacology , Wnt Proteins/genetics , Wnt Proteins/metabolism
7.
Neoplasia ; 11(3): 237-46, 1p following 246, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19242605

ABSTRACT

Early detection of precancerous tissue has significantly improved survival of most cancers including colorectal cancer (CRC). Animal models designed to study the early stages of cancer are valuable for identifying molecular events and response indicators that correlate with the onset of disease. The goal of this work was to investigate magnetic resonance (MR) colonography in a mouse model of CRC on a clinical MR imager. Mice treated with azoxymethane and dextran sulfate sodium were imaged by serial MR colonography (MRC) from initiation to euthanasia. Magnetic resonance colonography was obtained with both T1- and T2-weighted images after administration of a Fluorinert enema to remove residual luminal signal and intravenous contrast to enhance the colon wall. Individual tumor volumes were calculated and validated ex vivo. The Fluorinert enema provided a clear differentiation of the lumen of the colon from the mucosal lining. Inflammation was detected 3 days after dextran sulfate sodium exposure and subsided during the next week. Tumors as small as 1.2 mm(3) were detected and as early as 29 days after initiation. Individual tumor growths were followed over time, and tumor volumes were measured by MR imaging correlated with volumes measured ex vivo. The use of a Fluorinert enema during MRC in mice is critical for differentiating mural processes from intraluminal debris. Magnetic resonance colonography with Fluorinert enema and intravenous contrast enhancement will be useful in the study of the initial stages of colon cancer and will reduce the number of animals needed for preclinical trials of prevention or intervention.


Subject(s)
Colitis/diagnosis , Colonic Neoplasms/diagnosis , Early Detection of Cancer , Inflammation/diagnosis , Magnetic Resonance Imaging , Animals , Colitis/complications , Contrast Media/administration & dosage , Disease Models, Animal , Disease Progression , Enema , Fluorocarbons/administration & dosage , Mice
8.
Mol Carcinog ; 45(12): 943-56, 2006 Dec.
Article in English | MEDLINE | ID: mdl-16865672

ABSTRACT

The present study utilized microarray technology as a tool to elucidate the molecular signatures of soy-derived phytochemicals in the human androgen-responsive prostate cancer cell line LNCaP. Global gene expression pattern analysis of LNCaP cells exposed to 0, 1, 5, or 25 microM of the soy-derived phytochemicals equol and daidzein were conducted and compared. The data were further compared with previously generated data from exposure of LNCaP cells to the same doses of genistein, a soy isoflavone. Multidimensional scaling (MDS) analyses of the expression patterns suggest that these compounds exerted differential effects on gene expression in LNCaP cells. Further examination of specific gene changes revealed that these compounds differentially modulated genes in multiple cellular pathways, including the cell-cycle pathway genes. However, the three compounds also exerted similar effect on genes belonging to several other important cellular pathways. A universal effect of the three compounds on androgen-responsive genes, IGF-1 pathway gene, and MAP kinase-related pathway gene was observed. These results provide the foundation for establishing molecular signatures for equol, daidzein, and genistein. Moreover, these results also allow for the identification of candidate mechanism(s) by which soy phytochemicals and soy may act in prostate cancer cells.


Subject(s)
Androgens/metabolism , Gene Expression Profiling , Gene Expression/drug effects , Glycine max/chemistry , Neoplasms, Hormone-Dependent/genetics , Phytoestrogens/pharmacology , Prostatic Neoplasms/genetics , Cell Cycle/genetics , Cell Line, Tumor , Equol , Genistein/analysis , Genistein/pharmacology , Humans , Insulin-Like Growth Factor I/metabolism , Isoflavones/analysis , Isoflavones/pharmacology , Male , Neoplasms, Hormone-Dependent/metabolism , Oligonucleotide Array Sequence Analysis , Phytoestrogens/analysis , Prostatic Neoplasms/metabolism , Receptor, IGF Type 1/genetics
SELECTION OF CITATIONS
SEARCH DETAIL